The GRIN2B gene helps build part of an NMDA receptor, a brain cell signal receiver that supports learning, memory, and early brain development. If this gene does not work properly, brain signaling can become too weak or too strong. Pathogenic variants in the GRIN2B gene can cause a neurodevelopmental condition, often with developmental delay, intellectual disability, low muscle tone, seizures, or autism features. Symptoms vary widely, and some people are more mildly affected than others.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding processes in the body. Some genes carry the information needed to make proteins, the working parts of cells. Others mostly help regulate when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
GRIN2BGene function
What if the gene works
The GRIN2B gene helps make part of a receiver on brain cells that responds to glutamate, a key signaling chemical. This supports brain development, learning, memory, and normal communication between nerve cells.
Risk
What if the gene does not work
Variants in the GRIN2B gene can affect signaling and are linked to developmental conditions, often causing delayed development, intellectual disability, and sometimes seizures or autism features. Mild and severe variants can shape when symptoms appear and how strong they are.
Treatment
What does that mean for your treatment
No GRIN2B-specific treatment or management approach is currently established in clinical guidelines, including for loss-of-function variants. The GRIN2B gene is being studied to see whether some variants, especially those that increase receptor activity, might help guide experimental use of NMDA receptor blockers, but this is not standard care.
Conditions associated with GRIN2B
Gene function
What if the gene works
In the brain, the GRIN2B gene helps nerve cells respond to important chemical messages. It supports the flow of signals that let brain cells communicate, adapt, and build lasting connections. Understanding how the GRIN2B gene supports brain signaling helps explain everyday functions like learning, memory, and normal brain development.
The GRIN2B gene helps make part of an NMDA receptor, a gate on nerve cells that responds to glutamate, a brain signaling chemical. This helps brain cells receive and shape incoming messages.
By helping control this signal gate, the GRIN2B gene supports synaptic plasticity, which means connections between nerve cells can strengthen or adjust with experience. This process underlies learning and memory.
During brain development, this gene helps guide how nerve cell connections are formed and refined. It supports the organized wiring that helps different parts of the brain work together.
When NMDA receptors open, a small amount of calcium enters the nerve cell and acts as an internal messenger. This helps the cell adjust its activity and turn on programs needed for normal brain function.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal differences among people, including appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GRIN2B gene can change the shape, stability, or cell surface delivery of its protein, so NMDA receptor signaling may become weaker, stronger, or less well controlled. How GRIN2B gene variants affect NMDA receptor signaling depends on the change: milder variants may partly shift receptor activity, while more disruptive variants can sharply reduce function or make the channel overactive. Larger functional changes are often linked to earlier or more wide ranging developmental effects.
How variants are linked to conditions
Pathogenic variants in the GRIN2B gene can cause GRIN2B-related neurodevelopmental disorder. In reports on how GRIN2B gene variants are linked to conditions, the main findings are developmental delay or intellectual disability, speech delay, low muscle tone, movement differences, and sometimes seizures, autism features, or behavioral differences. The exact mix and severity can vary widely from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks related to the GRIN2B gene. For families, risk can be higher when a parent carries a GRIN2B variant, and sometimes a change can happen for the first time in a child.
Inheritance of GRIN2B variants
GRIN2B-related conditions usually follow an autosomal dominant inheritance pattern, which means one altered copy of the GRIN2B gene can be enough to cause the condition. In families, this means an affected parent can pass the variant to each child with a 50% chance. Many cases of GRIN2B inheritance happen because of a new (de novo) variant, so the change appears in the child and was not inherited from either parent. Both males and females can inherit and pass on GRIN2B variants.
What does my GRIN2B result mean for my family?
GRIN2B-related conditions usually follow a dominant family pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. In many families, though, the change happened for the first time in the affected person, so a parent does not always have it. Whether relatives might want testing depends on the exact GRIN2B result found in your family.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the GRIN2B gene, genetic testing for GRIN2B variants analyzes DNA from a blood sample, cheek swab, or saliva. A lab reads the gene’s code and compares any variant it finds with medical evidence to classify it as benign, uncertain, or likely related to disease.
When should I consider getting a genetic test?
Genetic testing for the GRIN2B gene may be considered if a child has unexplained developmental delay, speech delay, autism, seizures, or learning problems, especially when several of these happen together. It can also be useful when a close family member has a known GRIN2B change or a similar pattern of symptoms.
A genetic result is only one part of your health story
Genetic testing can provide useful information, but how much it explains varies with the condition and the kind of variant that is present. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered together with other parts of care. In other situations, a genetic result can give a clear answer. In fields like medication response, genetic results may also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes that help the body absorb, break down, transport, or respond to a drug can mean the same treatment works well for one person but less well for another, or causes more side effects. This kind of variation is common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes can influence either how strongly a drug works or how the body handles it. This information can support treatment choices that are both more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the GRIN2B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so concerns about symptoms, treatment, or side effects are best discussed with your doctor. GRIN2B has been studied in research on response to some medicines that affect brain signaling, but these findings are not used routinely in everyday care.
History
Across cultures and time periods, inherited patterns were noted, but the GRIN2B gene entered medical research much later through studies of brain signaling in the late 20th century. In the 1990s, scientists identified GRIN2B as part of a group of genes important for early brain development and learning. From these first observations, research expanded steadily. By the 2000s and 2010s, improved DNA testing linked variants in the GRIN2B gene to developmental differences, including delays in speech, movement, and learning. This helped shift care from describing symptoms alone to recognizing a specific genetic cause in some families. Over time, these findings made the GRIN2B gene an established part of neurodevelopmental genetics.